Jaa Roberson

Human Resources Officer at DAY ONE BIOPHARMACEUTICALS, INC.

Health Technology

Consumer Services

Profile

Jaa Roberson is currently the Chief People Officer at Day One Biopharmaceuticals, Inc. Prior to this, she worked as the Head of Human Resources at Achaogen, Inc. and as the Vice President of Human Resources at Bellicum Pharmaceuticals, Inc. from 2018 to 2020.
Ms. Roberson has an undergraduate degree from Rice University and a graduate degree from the San Francisco Conservatory of Music.

Jaa Roberson active positions

Companies	Position	Start
DAY ONE BIOPHARMACEUTICALS, INC.	Human Resources Officer	12/09/2021

All active positions of Jaa Roberson

Former positions of Jaa Roberson

Companies	Position	End
BELLICUM PHARMACEUTICALS, INC.	Human Resources Officer	31/10/2020
ACHAOGEN	Human Resources Officer	-

See the detail of Jaa Roberson's experience

Training of Jaa Roberson

Rice University	Undergraduate Degree
San Francisco Conservatory of Music	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jaa Roberson's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
DAY ONE BIOPHARMACEUTICALS, INC.	Health Technology

Private companies	2
Achaogen, Inc. Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA.	Health Technology
Bellicum Pharmaceuticals, Inc. Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX.	Health Technology

Private companies